Brillia Health Cough Control by Hadaf LLC / Santonika Uab 72123-005 Cough Control

Brillia Health Cough Control by

Drug Labeling and Warnings

Brillia Health Cough Control by is a Homeopathic medication manufactured, distributed, or labeled by Hadaf LLC, Santonika Uab. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

BRILLIA HEALTH COUGH CONTROL- homeopathic tablet 
Hadaf LLC

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

72123-005 Cough Control

Active Ingredients

Lapine bradykinin immune globulin 12C, 30C, 50C Purpose Reduces frequency and intensity of cough
Lapine morphine immune globulin 12C, 30C, 50C Purpose Reduces pain response
Lapine histamine immune globulin 12C, 30C, 50C Purpose.Reduces histamine and inflammation response

Purpose

Homeopathic,
Reduces frequency and intensity of cough
Reduces pain responseLapine histamine immune
Reduces histamine and inflammation response

Uses

Suppresses wet and dry cough
Reduces severity and duration of symptoms, including nasal congestion, cough and sore/itchy throat
Antihistamine and decongestant/anti-inflammatory
Reduces sore throat pain

Warnings

Stop use and ask a doctor if symptoms persist or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Allergic (hypersensitivity) reactions may occur in very rare cases.
Do not use if known sensitivity to Brillia Health Cough Control or
any of its ingredients exists.

Stop use

Stop use and ask a doctor if symptoms persist or worsen.

Pregnancy

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Allergies

Allergic (hypersensitivity) reactions may occur in very rare cases.

Do Not Use

Do not use if known sensitivity to Brillia Health Cough Control or
any of its ingredients exists.

Directions

For adults and children 3 years and older.
Take orally by holding tablet in the mouth until completely dissolved, without food.
1 to 2 tablets 3 times daily.
For severe symptoms, take 4 to 6 times daily for the first 3 days.

Other Information

Store in original package below 25°C or 77°F.
Do not use if blister pack is torn or broken.

Inactive ingredients

Isomalt, Microcrystalline cellulose, Magnesium stearate, Citric acid (anhydrous), Aspartame, Sodium saccharin.

20 Tablets NDC: 72123-005-01

LABEL 1

BRILLIA HEALTH COUGH CONTROL 
homeopathic tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 72123-005
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LAPINE MORPHINE IMMUNE GLOBULIN (UNII: OS064NQ92E) (LAPINE MORPHINE IMMUNE GLOBULIN - UNII:OS064NQ92E) LAPINE MORPHINE IMMUNE GLOBULIN12 [hp_C]  in 12 [hp_C]
LAPINE BRADYKININ IMMUNE GLOBULIN (UNII: FX59DZ02OS) (LAPINE BRADYKININ IMMUNE GLOBULIN - UNII:FX59DZ02OS) LAPINE BRADYKININ IMMUNE GLOBULIN12 [hp_C]  in 12 [hp_C]
LAPINE HISTAMINE IMMUNE GLOBULIN (UNII: 7U4T47R0DD) (LAPINE HISTAMINE IMMUNE GLOBULIN - UNII:7U4T47R0DD) LAPINE HISTAMINE IMMUNE GLOBULIN12 [hp_C]  in 12 [hp_C]
Inactive Ingredients
Ingredient NameStrength
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
ISOMALT (UNII: S870P55O2W)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
ASPARTAME (UNII: Z0H242BBR1)  
SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
Product Characteristics
ColorwhiteScorescore with uneven pieces
ShapeROUNDSize9mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 72123-005-0112 [hp_C] in 1 BLISTER PACK; Type 0: Not a Combination Product07/31/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic07/31/202008/07/2020
Labeler - Hadaf LLC (094114708)
Establishment
NameAddressID/FEIBusiness Operations
Santonika Uab520214047manufacture(72123-005)

Revised: 1/2022

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.